Xie Yong, Zhang Lihai, Gao Yanpan, Ge Wei, Tang Peifu
Department of Orthopedics, General Hospital of Chinese PLA, Beijing 100853, China.
National Key Laboratory of Medical Molecular Biology, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, China.
Molecules. 2015 Oct 23;20(10):19433-48. doi: 10.3390/molecules201019433.
Bone metabolism is a lifelong process for maintaining skeletal system homeostasis, which is regulated by bone-resorbing osteoclasts and bone-forming osteoblasts. Aberrant differentiation of osteoclasts and osteoblasts leads to imbalanced bone metabolism, resulting in ossification and osteolysis diseases. MicroRNAs (miRNAs) are pivotal factors in regulating bone metabolism via post-transcriptional inhibition of target genes. Recent studies have revealed that miR-223 exerts multiple effects on bone metabolism, especially in the processes of osteoclast and osteoblasts differentiation. In this review, we highlight the roles of miR-223 during the processes of osteoclast and osteoblast differentiation, as well as the potential clinical applications of miR-223 in bone metabolism disorders.
骨代谢是维持骨骼系统稳态的终身过程,由骨吸收破骨细胞和成骨成骨细胞调节。破骨细胞和成骨细胞的异常分化导致骨代谢失衡,从而引发骨化和骨溶解疾病。微小RNA(miRNA)是通过对靶基因的转录后抑制来调节骨代谢的关键因素。最近的研究表明,miR-223对骨代谢具有多种作用,尤其是在破骨细胞和成骨细胞分化过程中。在这篇综述中,我们重点介绍了miR-223在破骨细胞和成骨细胞分化过程中的作用,以及miR-223在骨代谢紊乱中的潜在临床应用。